247 related articles for article (PubMed ID: 8412316)
1. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
2. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
[TBL] [Abstract][Full Text] [Related]
5. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
[TBL] [Abstract][Full Text] [Related]
10. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
11. Involvement of p53 gene mutations in human endometrial carcinomas.
Honda T; Kato H; Imamura T; Gima T; Nishida J; Sasaki M; Hoshi K; Sato A; Wake N
Int J Cancer; 1993 Apr; 53(6):963-7. PubMed ID: 8473053
[TBL] [Abstract][Full Text] [Related]
12. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
13. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.
Fenaux P; Preudhomme C; Laï JL; Quiquandon I; Jonveaux P; Vanrumbeke M; Sartiaux C; Morel P; Loucheux-Lefebvre MH; Bauters F
Leukemia; 1992 Apr; 6(4):246-50. PubMed ID: 1588788
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
17. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I
Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
19. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
20. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]